「NET TALK」肝癌研究的前沿发现

讲述值得探索的营养新思维

ICNYSN-NET TALK

Nutrition·Exploring·Thinking

NET TALK-Youth
在线讲座开启
受邀嘉宾 Invited Guest
张学宏 博士 
Dr. Xuehong Zhang
哈佛大学助理教授，流行病学和营养学博士，肿瘤流行病学家。

Assistant Professor of Harvard Medical School and Harvard Chan School; Cancer epidemiologist with expertise in clinical medicine and nutrition.

演讲主题  Theme

肝癌研究的前沿发现

Cutting-edge research findings on liver cancer

在这次讲座上，张博士将介绍有关肝癌的最新研究进展。在美国，肝癌是男性和女性中发病率增长最迅速的疾病之一，加上中位生存期不到一年。因此，确定可改变的风险因素以预防肝癌的发生是降低肝癌发病率和死亡率的关键重点之一。因此，在慢性肝炎感染率相对较低的美国，人们对肝癌的非感染病因仍知之甚少。张博士的研究目标之一是为一级预防策略提供信息，确定新的尤其是可改变的肝癌危险因素。这些研究发现对肝癌的病因和预防策略有潜在的贡献。
For this seminar, Dr. Zhang will introduce cutting-edge research findings on liver cancer. In the United States, liver cancer has one of the most rapidly increasing incidence rates among both men and women, coupled with a median survival of less than one year. Hence, identification of modifiable risk factors to prevent the development of liver cancer is one of the key priorities to reduce liver cancer morbidity and mortality. The etiology of liver cancer remains poorly understood in the US, where hepatitis infections are relatively low. One of Dr. Zhang’s research goals is to identify new modifiable risk factors for liver cancer to inform primary prevention strategies. In this seminar, Dr. Zhang will share some research findings on liver cancer. These findings have the potential to inform disease etiology, and strategies for liver cancer prevention.
全球同步直播 Global Live Streaming

美国东部（EST）时间

2021/7/29（周四）9:00AM

美国西部（PST）时间

2021/7/29（周四）6:00AM

北京时间

2021/7/29（周四）9:00PM

演讲嘉宾专业背景简介 Guest Professional background 
张学宏 博士 

在哈佛大学 Chan 学院获得流行病学和营养学博士学位。研究目标是降低癌症发病率和死亡率，包括:

  • 癌症的一级预防：确定结直肠肿瘤和肝癌的新病因；将新技术整合到纵向队列中，以更好地了解暴露和癌症关联的生物学机制。

  • 二级预防：利用一般人群和肝病患者的临床队列，开展生物标志物研究，为肝癌的早期发现和诊断提供信息。

  • 三级预防：确定新的饮食，生活方式和生物因素单独或结合现有的治疗方法，以提高癌症生存者的生活质量。

张博士的研究主要由美国国立卫生研究院和美国癌症协会支持。他的工作已经发表了160多篇原创研究论文。他热衷于教学和辅导，并在哈佛商学院和其他一些机构提供客座讲座。

Dr. Xuehong Zhang is a cancer epidemiologist with training in clinical medicine and nutrition. He obtained a doctoral degree in Epidemiology and Nutrition from the Harvard Chan School. His research goal is to decrease cancer morbidity and mortality, including:

  • Primary prevention: identify new etiological factors for both colorectal neoplasia and liver cancer; integrate new technologies into longitudinal cohorts to better understand the biological mechanisms underlying exposures and cancer associations.

  • Secondary prevention: conduct biomarker research to inform early detection and diagnosis of liver cancer by leveraging general population and clinical cohorts of patients of liver diseases.

  • Tertiary prevention: identify new dietary, lifestyle, and biological factors alone or in combination of existing treatments to improve quality of life among cancer survivors.

Dr. Zhang’s research has been primarily supported by the National Institutes of Health and American Cancer Society. His work has resulted in over 160 original research publications. He is passionate about teaching and mentoring, and he also offers guest lectures at the Harvard Chan School and several other institutions.

赞 (0)

相关推荐